15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Calumet Specialty Products Partners, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $13.25 to $60.00 (about 4.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $35.75 sits 13% below the current $41.27. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.47 next quarter toward $0.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Calumet Specialty Products Partners.
As of Jul, 2 of 3 firms rate CLMT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CLMT EPS & revenue forecast
EPS · NEXT QUARTER
$0.47
Range $0.47 – $0.47 · 1 analysts · +129% YoY
Next period, 1 analysts expect Calumet Specialty Products Partners to earn $0.47 a share (range $0.47 – $0.47), versus $0.20 a year earlier. Full-year consensus is $-2.84, growing to $0.42 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $973.6M – $1.4B · 1 analysts · +13% YoY
Revenue is expected to reach $1.2B (range $973.6M – $1.4B), +12.8% year-over-year. Full-year consensus is $4.6B, rising to $4.8B next year.
Top analysts covering Calumet Specialty Products Partners
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLMT.
#1
Roger Read
Wells Fargo · Rank #24
Buy
$21.00-49.1% to target
Overall win rate
49%
+ Follow
#2
Neil Mehta
Goldman Sachs · Rank #59
Buy
$34.00-17.6% to target
Overall win rate
42%
+ Follow
#3
Amit Dayal
HC Wainwright & Co. · Rank #332
Buy
$60.00+45.4% to target
Overall win rate
25%
+ Follow
#4
Jason Gabelman
TD Cowen
Hold
$25.00-39.4% to target
Coverage
—
+ Follow
#5
Manav Gupta
UBS
Hold
$26.00-37.0% to target
Coverage
—
+ Follow
CLMT stock forecast FAQ
What is CLMT's average 12-month price target?+
The 3 analysts with a live target average $35.75 for Calumet Specialty Products Partners over the next 12 months, ranging from a $60.00 high to a $13.25 low.
Is CLMT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CLMT?+
The Street-high target is $60.00 (HC Wainwright & Co.), and the Street-low is $13.25 (UBS). The average of all 3 active targets is $35.75.
How many Wall Street analysts cover CLMT?+
3 analysts have an active rating on Calumet Specialty Products Partners, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLMT?+
Among analysts who currently cover CLMT, Roger Read of Wells Fargo has the strongest overall Quantellect track record (Rank #24). Their current call is Buy with a $21.00 target.
What is Calumet Specialty Products Partners's projected EPS for next quarter?+
The consensus estimate is $0.47 per share (range $0.47 – $0.47) across 1 analysts. Full-year EPS is projected at $-2.84, rising to $0.42 the following year.
How much revenue is Calumet Specialty Products Partners expected to report next quarter?+
Consensus revenue is $1.2B (range $973.6M – $1.4B). Full-year revenue is projected at $4.6B, growing to $4.8B next year.
Have analysts been upgrading or downgrading CLMT lately?+
As of Jul, 2 of 3 firms rate CLMT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLMT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
